Home › Melanoma › Texas › Dallas

Pag-aaral pangklinika para sa Melanoma sa Dallas, TX

Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral

Research Site, Dallas

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Nagre-recruitPhase 3

Texas Oncology - Medical City, Dallas
Texas Oncology, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06246916

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Baylor, Scott and White Research Institute, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Nagre-recruitPhase 1/2

UT Southwestern, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288112

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1/2

Texas Oncology - Dallas SCRI, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07287917

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2

Texas Oncology, P.A., Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Nagre-recruitPhase 1/2

Call for Information (Investigational Site 0054), Dallas

6 Months – 17 Years · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT02332668

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

Nagre-recruitObservasyonal na pag-aaral

University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT06400550

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Nagre-recruitPhase 3

Texas Retina Associates - Dallas, Dallas
University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07015190

A Study of VET3-TGI in Patients With Solid Tumors

Nagre-recruitPhase 1

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Nagre-recruitPhase 2/3

UT Southwestern Medical Center, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Nagre-recruitPhase 1/2

Research Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06956690

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07317505

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 120, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT04370587

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology, Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2024 · NCT05746897

Pag-aaral para sa Melanoma sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.